Pulsed Electromagnetic Field ( Diapulse)
in Management of Head Injuries
|
M. Sambasivan
Former Director & Prof Neurosurgery,
Medical College Hospital, Trivandrum - 695 011.
Consultant Neurosurgeon, Cosmopolitan Hospital,
Trivandrum - 695 004.
Address for Correspondence: Dr. M. Sambasivan, "SI VAPRIYA",
No. 2,
Tagore Gardens, Trivandrum - 695 011. Kerala (India), Pone:
71054. |
| Summary |
Having found that Pulsed Electromagnetic Field (PEMF) is useful
in reducing cerebral oedema, tissue and scalp oedema, it was
used in managing acute bead injury cases. Cases with Glasgow
Coma Scale (GCS) 8 or less were taken up. Cases with haematomas
or other treatable lesions were excluded. Alternate cases received
PEMF therapy. Thus 100 cases were treated and 100 cases acted
as controls. The treated cases showed better improvement. Their
follow up to one year is presented herewith. Role of this energy
in treating Extradural haematomas is highlighted. Key
words: Head Injury, Pulsed Electromagnetic Field. |
| Introduction |
| The varied biological effects of pulsed electromagnetic energy
is emerging as beneficial in the management of many clinical
situations. (O’Connor et al, 1990) Experience with this
energy in experimental studies has also shown the beneficial
effects in reducing cerebral oedema (Jayakumar etal, 1986, Aron
and Rema, 1983; Sharrard etal, 1983; Wilson, 1972; Wright, 1973,
Young etal, 1984) |
| Materials and Methods |
Two hundred cases of acute head injuries
with Glasgow Coma Scale (GCS) 8 or less were taken up for
this study. Cases with haematoma or other treatable lesions
were excluded from this group. Alternate cases were given
pulsed electromagnetic energy therapy. Thus 100 cases received
treatment and 100 cases acted as controls. Cases were seen
in the casualty and then on admission. The Glasgow Coma Scales
were recorded. Thus the cases with diffuse brain damage, multiple
contusions and brain oedema in poor states of consciousness
- Scale 8 or less were taken up for study.
All cases were treated in the intensive care unit and the
same management protocol was followed except that in alternate
cases PEMF therapy was also given. Daily clinical assessment
of GCS, maintenance of fluid and electrolyte balances and
adequate nutrition was managed. Physiotherapy to augment respiratory
movements, care of skin, bladder and bowel management was
uniform in both groups of cases. Intraventricular pressure
measurements were done in 20 cases. PEMF therapy was given
in a setting 65/U Sec. pulses of RE 27.12MHz at 600 pulses
per second for 30 minutes, 12 hrly. Electromagnetic head was
placed over the patient’s head. Alternate side right
and left were treated. This was started from the time of admission
into the intensive care unit. All cases had CT Scan of the
head.
Figure I shows the graph of cases with OCS on admission and
at 10th day as regards the PEMF treated cases. Figure 2 shows
the same feature as regards the control group. It is notable
that in both groups same number of cases died. But there is
a definite qualitative improvement in the survivors who received
PEMF therapy.
 
Figure 1
Figure
2
Serial CT Scans were done and they were compared with the
controls. Figures 3 and 4 show the CT of ‘Ka’
on 2nd post head injury day and at 10th day. In the first
picture there is clear evidence of oedema and ventricles appear
slit like. By 10th day there is disappearance of oedema and
the ventricles are seen well. However, in the control cases
it took longer ie., 12 to 15 days to see the ventricles. Similar
improvement was noted in a 68-year old man with multiple contusions.
By 10 days it is seen that his contusions have been absorbed
and there is a hypodense subdural haematoma (Figures 5 and
6). Patient improved well and the subdural needed tapping
trough a drill hole once. He was able to support himself at
the time of discharge.
ICP measurements using intraventricular catheter was done
in the first 20 cases. Of them 10 cases had PEMF therapy.
It was noted that in the treated cases, the LCP tended to
diminish from 5th day from 300mm of water. By 7th day it came
to near normal levels of 200 to 250mm of H20. Among the controls
the intracranial pressure was beginning to diminish only by
the 7th day. Dehydration therapy to combat cerebral oedema
was needed in the control cases and only rarely needed in
the treated cases. CSF temperature did not rise with PEMF
therapy.
After 10th day the cases were shifted out of intensive care
ward. The patients were referred to Department of Physical
Medicine and Rehabilitation. The relatives were taught basic
movements, shifting positions and minimal physiotherapy. This
was regularly supervised by the departmental staff. The relatives
felt an involvement in the management of cases. Patient’s
nutritional status, and electrolyte status were monitored
and adequately replaced.
 
Figure 3
Figure
4
Figures 7 and 8 show the status of the group vis-a-vis GCS
at 30 days. Again it is evident that the PEMF treated cases
did better. The improvement noted was rapid in the survivors.
In the group treated there were 4 deaths and in the untreated
group there were 8 deaths.
 
Figure 5
Figure 6
|
| Results |
Cases were followed up for 12 months. Overall
mortality at I month in the PEMF treated cases was 24% and amongst
the controls was 29%. The Glasgow Outcome Scale (GOS) at one
year was as follows:
Glasgow outcome scale
| PEMF |
Treated |
(76 Cases) |
| GOS |
1 |
11 |
| |
2 |
23 |
| |
3 |
24 |
| |
4 |
10 |
| |
5 |
6 |
Lost for follow up 2
| PEMF |
Controls |
(71 Cases) |
| GOS |
1 |
9 |
| |
2 |
16 |
| |
3 |
16 |
| |
4 |
13 |
| |
5 |
13 |
Lost for follow up 4
Overall at the end of 12 months the qualitative improvement
continued amongst the PEMF treated group. Overall mortality
at the end of 12 months for the PEMF treated group including
the two cases lost for follow up was 32% and for the controls
it was 46%.
 
Figure 7
Figure
8
When the good outcome groups, ie., GOS I and 2 are considered
for PEMF treated group it was 34% and the control (unrelated)
group it was 25% only.
Meanwhile four cases of extradural haematoma were treated conservatively
with PEMP energy with follow up CT scans. It so happened that
the first case in this group was admitted fully conscious with
no neurological deficits following a head injury (Fig. 9). The
patient and relatives did not want surgery. Hence patient had
PEMF energy therapy twice daily for 10 days. Fig. 10 shows the
CT taken after the 10th day showing clearance of the haematoma.
Three more cases were treated similarly with good results.
 
Figure 9
Figure 10
In small or asymptomatic extradural haematoma, PEMF energy therapy
has a role in the conservative management. Follow up with serial
CT scan is mandatory. |
| Conclusions |
| 1. Pulsed electromagnetic energy therapy has a definite role
in the management of acute head injuries. The treated group
has shown better quality improvement and lesser mortality. 2.
There is a role for PEMF therapy in the conservative management
of Extradural haematomas. |
| References |
1. O’Connor MEO, Bentall RHC, Monohan JC (Eds) Emerging
Electromagnetic medicine. Springer-Verlag 1990.
2. Jayakumar K, Rajagopalan I, Sambasivan M. Seemanthini Bai,
A: Effect of Pulsed Electromagnetic Field (PEMF) in cerebral
Oedema. Neurology India 34, 24 1-247, 1986.
3. Raji ARM, Bowden REM: Effects of high peak pulsed electromagnetic
field on the degeration and regeneration of the common peroneal
nerve in rat. Journal of Bone and Joint Surgery 65 B, 3, 1983.
4. Sharrard WJW, Suteliffe ML, Robson Mi, Maccacheran AG: Treatment
of fibrous nerve union of fracture by PEMF stimulations. Journal
of Bone and Joint Surgery 64 B, 189-193, 1983.
5. Wilson DH: Treatment of soft tissue injuries by pulsed electrical
energy. British Medical Journal 2, 269-270, 1972.
6. Wright GG: Treatment of soft tissue and ligamentous injuries
in professional footballers. Physiotherapy 59, 385-387, 1973.
7. Young W, Decrescito V, Flamen ES, Ransohoff J: Pulsed electromagnetic
field and methyl prednisolone after calcium and functional recovery
in spinal cord injury. Paper presented at AANS annual meeting,
1984.
The PEMF unit used in this study was Diapulse Therapy, manufactured
exclusively by the Diapulse Corporation of America, 321 East
Shore Road, Great Neck, NY I 1023, U.S.A. |
|